
Gossamer Bio (GOSS) Net Income
Price: $0.9583
Market Cap: $217.75M
Avg Volume: 1.63M
Market Cap: $217.75M
Avg Volume: 1.63M
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
What is Gossamer Bio's Net Income?
- Gossamer Bio's annual net income as of FY 2024 is $-56.53M.
- Gossamer Bio's quarterly net income as of Q4 2024 is $-33.03M.
What is Net Income?
Net income is the total profit of a company after all expenses and taxes have been deducted from revenue. It is also known as net profit or net earnings and is a key indicator of a company's financial performance and profitability.
Related Metrics
Other important metrics to assess Gossamer Bio's financial health include:
- Net Income Growth - the rate at which a company's net income is growing:
- Annual Growth: 68.56%
- Net Income Ratio - net income divided by revenue:
- Annual: -49.28%
- Quarterly: -352.16%
- Net Income Per Share - net income divided by the number of shares outstanding:
- Annual: $-0.25
These metrics provide insights into Gossamer Bio's financial health and its profitability. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
Annual Net Income
$-56.53M
Quarterly Net Income
$-33.03M
Historical Annual Net Income
Historical Quarterly Net Income
Annual Net Income Growth
Annual Net Income Per Share
Gossamer Bio Historical Net Income Metrics
The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.
Year | Net Income | Net Income Growth | Net Income Ratio | Net Income Per Share |
---|---|---|---|---|
2024 | $-56.53M | 68.56% | -49.28% | $-0.25 |
2023 | $-179.82M | 25.15% | - | $-1.18 |
2022 | $-240.23M | 3.55% | - | $-2.84 |
2021 | $-249.08M | 1.00% | - | $-3.33 |
2020 | $-251.58M | -39.14% | - | $-3.67 |
2019 | $-180.82M | -23.03% | - | $-3.30 |
2018 | $-146.97M | -2070.57% | - | $-2.43 |
2017 | $-6.77M | -8057.83% | - | $-0.27 |
2016 | $-83.00K | 0.00% | - | $0.00 |